Transfer Sheet for Patient in-Bed Transferring and Repositioning

Name: Transfer Sheet for Patient in-Bed Transferring and Repositioning
Brand: GUANGZHOU TOPMEDI CO., LTD.
SKU: 1999121775

Guangdong, ChinaGUANGZHOU TOPMEDI CO., LTD.

US$5.60-8.40

100 Pieces

Product profile

Customization

Available

Customized

Certification

Model NO.

TRA-3114

Scale

Medium

Packing

OPP

Transport Package

1 PC/Carton

Trademark

Topmedi

Origin

China

Production Capacity

100000PCS/Year

Company profile

GUANGZHOU TOPMEDI CO., LTD.

Guangdong, China

Business Type: Trading Company CertifiedR&D Capacity: ODM Service Available CertifiedCustomization Options: Flexible customization CertifiedExport Year: 13 Years CertifiedNearest Port: Guangzhou Port, Shenzhen PortAverage Response Time: ≤6.80h

AI-Powered supplier vetting

SummaryGuangzhou Topmedi Co., Ltd. is identified as a trading company in Guangzhou, with stated SGS approval and EU CE certification for its products. The supplier reports quality assurance, 11–20 quality-control staff, 10 production lines, substantial stated product outputs, and exports to multiple global regions; however, its trading-company classification creates uncertainty regarding direct manufacturing control. It reports recent new-product development and ODM availability, but no SDK and no OEM service for popular brands. Service infrastructure is limited: there are no written complaint-handling or corrective-action procedures, no stock, overseas warehouse, overseas showroom, or overseas agents/branches. The supplier has participated in the CMEF trade show and uses ERP for digital process management. Financial credibility cannot be assessed because the provided information does not establish financial strength, contract validity, or other financial evidence.

CertificationsThe company description states that the supplier was approved by SGS and that its products passed EU CE certification issued by NQA, a UKAS-accredited third-party certification body. These statements provide explicit evidence of certification-related credentials, although the evidence is presented as company-declared information rather than attached certificates or scope details.

After-Sales capabilityAfter-sales and service controls are weakly documented: there are no written complaint-handling procedures, no corrective and preventive action procedures or records, and no written service-capability assessment procedures. The supplier also reports no stock service, overseas warehouse, overseas showroom, overseas agents, or branches, although it has participated in the CMEF offline trade show.

R&D capabilityThe supplier reports having launched new products within the past year and offering ODM services, which supports product-development capability. However, it has no available SDK; ERP integration is reported, while OA and CRM are recorded only as present and SAP as absent, so the broader innovation infrastructure is only partially evidenced.

Production capacityThe supplier reports 10 production lines, 11–20 quality-control staff, and substantial stated output across wheelchairs, walking aids, hospital beds, bath chairs, and commodes, with exports to multiple regions. However, it is classified as a trading company, has no in-stock capability, and its manufacturing-capacity contract status is unknown, so direct production control is not fully established.

Customization capabilityODM service availability and recent new-product development provide explicit evidence that the supplier can support at least some product customization or design-manufacturing work. It does not provide OEM services for popular brands and has no SDK, so the scope of customization is limited and not fully defined.